TrialNature aging2021

Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer's disease.

Jiansong Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.